Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000295646 | SCV000342217 | uncertain significance | not provided | 2016-05-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000805748 | SCV000945716 | uncertain significance | Qualitative or quantitative defects of dysferlin | 2022-06-13 | criteria provided, single submitter | clinical testing | This variant, c.6154_6165dup, results in the insertion of 4 amino acid(s) of the DYSF protein (p.Ile2052_Ile2055dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs770728402, gnomAD 0.01%). This variant has been observed in individual(s) with limb-girdle muscular dystrophy (PMID: 17994539). ClinVar contains an entry for this variant (Variation ID: 288182). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV000295646 | SCV005079460 | likely pathogenic | not provided | 2023-12-08 | criteria provided, single submitter | clinical testing | Identified in patients with limb-girdle muscluar dystrophy phenotypes without a second DYSF allele defined in the published literature (PMID: 17994539, 34559919); In-frame duplication of 4 amino acids in a non-repeat region; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 24438169, 34559919, 17994539) |
Natera, |
RCV001828249 | SCV002080361 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2020-08-18 | no assertion criteria provided | clinical testing |